研究文章
临床、组织病理学和前列腺癌患者的预后特征在卢本巴希,刚果民主共和国
|
| 变量 |
(幸存下来n= 50) |
已故的(n= 24) |
失访(n= 14) |
价值 |
|
| 年龄(年) |
|
|
|
|
| 意思是(范围) |
68.48 (49 - 90) |
68.79 (47 - 83) |
69.57 (60 - 80) |
0.905 |
|
| PSA水平诊断(ng / ml) |
|
|
|
|
| 意思是(范围) |
80.38 (6.5 - -89.32) |
268.35 (9 - 1564.50) |
93.53 (4 - 251.00) |
0.007 |
|
| PSA水平在3个月的随访(ng / ml) |
|
|
|
|
| 意思是(范围) |
28.44 (0.16 - -87.12) |
357.66 (88.13 - -1782.10) |
73.39 (0.23 - -201.16) |
< 0.0001 |
|
| 伴随疾病 |
|
|
|
0.6966 |
| 现在 |
14 (28.00%) |
9 (37.50%) |
4 (28.57%) |
|
| 缺席 |
36 (72.00%) |
15 (62.50%) |
10 (71.43%) |
|
|
| 前列腺直肠指诊 |
|
|
|
0.0013 |
| 正常的 |
35 (70.00%) |
6 (25.00%) |
8 (57.14%) |
|
| 不正常的 |
15 (30.00%) |
18 (75.00%) |
6 (42.86%) |
|
|
| D中保风险分类 |
|
|
|
0.1163 |
| 低风险 |
12 (24.00%) |
4 (16.67%) |
2 (14.29%) |
|
| 中间的风险 |
13 (26.00%) |
1 (4.17%) |
4 (28.57%) |
|
| 高的风险 |
25 (50.00%) |
19 (79.17%) |
8 (57.14%) |
|
|
| 格里森评分 |
|
|
|
0.0513 |
| < 7 |
19 (38.00%) |
3 (12.50%) |
4 (28.57%) |
|
| 7 |
19 (38.00%) |
8 (33.33%) |
7 (50.00%) |
|
| > 7 |
12 (24.00%) |
13 (54.17%) |
3 (21.43%) |
|
|
|
